Sun Mengying, Fang Yilong, Zheng Jianhua, Shi Guojuan, Guo Junli, Zhang Xinzhou, Zhang Rui
Department of Nephrology, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, Guangdong, China.
School of Pharmaceutical Sciences, Affiliated Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
Front Pharmacol. 2024 Jan 5;14:1306125. doi: 10.3389/fphar.2023.1306125. eCollection 2023.
Chronic kidney disease (CKD) is now globally recognized as a critical public health concern. Vascular calcification (VC) represents a significant risk factor for cardiovascular events in individuals with CKD. It is the accessible and precise diagnostic biomarkers for monitoring the progression of CKD and the concurrent VC are urgently needed. The adenine diet-induced CKD rat model was utilized to investigate chronic kidney injury, calcification in the kidney and thoracic aorta, and dysregulation of biochemical indices. Enzyme-linked immune sandwich assays were employed to analyze changes in calcification-related proteins. 16S rRNA sequencing was performed to delineate the microbiota characteristics in the gut and blood of CKD-afflicted rats. Additionally, transcriptome sequencing of kidney tissue was conducted to explore the relationship between CKD-associated microbiota features and alterations in kidney function. The adenine diet-induced CKD inhibited body weight gain, and led to kidney injury, and pronounced calcification in kidney and thoracic aorta. The microbiota both in the gut and blood of these affected rats exhibited significantly lower alpha diversity and distinctive beta diversity than those in their healthy counterparts. CKD resulted in dysregulation of several biochemical indices (including elevated levels of creatinine, low-density lipoprotein-cholesterol, sodium, phosphorous, total cholesterol, and urea and decreased levels of albumin, calcium, lactate dehydrogenase, and total bilirubin). Moreover, it upregulated calcification-related factors (bone sialoprotein [BSP], Klotho, fibroblast growth factor [FGF]-23, and sclerostin [SOST]) and lipopolysaccharide (LPS). Notably, the increased in the blood was positively associated with calcifications in the kidney and thoracic aorta, in addition to the positive correlation with gut microbiota. The enrichment of was concurrent with increases in calcification factors (BSP, FGF-23, and SOST), LPS, and phosphorous. Furthermore, transcriptome sequencing revealed that the enrichment of was positively correlated with the majority of upregulated genes and negatively correlated with downregulated genes involved in the mineral absorption pathway. Our findings, for the first time, underscore that dysbiosis of symbiotic microbiota, both in the gut and blood, is involved in the progression of CKD. Particularly, the enrichment of in blood emerges as a potential risk factor for CKD and its accompanying VC.
慢性肾脏病(CKD)目前在全球范围内被公认为是一个关键的公共卫生问题。血管钙化(VC)是CKD患者发生心血管事件的一个重要危险因素。目前迫切需要可获取且精确的诊断生物标志物来监测CKD的进展以及并发的VC。采用腺嘌呤饮食诱导的CKD大鼠模型来研究慢性肾损伤、肾脏和胸主动脉钙化以及生化指标的失调。采用酶联免疫夹心测定法分析钙化相关蛋白的变化。进行16S rRNA测序以描绘受CKD影响大鼠的肠道和血液中的微生物群特征。此外,对肾脏组织进行转录组测序以探索与CKD相关的微生物群特征与肾功能改变之间的关系。腺嘌呤饮食诱导的CKD抑制体重增加,并导致肾损伤以及肾脏和胸主动脉明显钙化。这些受影响大鼠的肠道和血液中的微生物群与健康大鼠相比,α多样性显著降低,β多样性独特。CKD导致多种生化指标失调(包括肌酐、低密度脂蛋白胆固醇、钠、磷、总胆固醇和尿素水平升高,白蛋白、钙、乳酸脱氢酶和总胆红素水平降低)。此外,它上调了钙化相关因子(骨唾液蛋白[BSP]、klotho、成纤维细胞生长因子[FGF]-23和硬化蛋白[SOST])以及脂多糖(LPS)。值得注意的是,血液中[此处原文缺失相关物质,无法准确翻译]的增加与肾脏和胸主动脉的钙化呈正相关,此外还与肠道微生物群呈正相关。[此处原文缺失相关物质,无法准确翻译]的富集与钙化因子(BSP、FGF-23和SOST)、LPS和磷的增加同时出现。此外,转录组测序显示[此处原文缺失相关物质,无法准确翻译]的富集与参与矿物质吸收途径的大多数上调基因呈正相关,与下调基因呈负相关。我们的研究结果首次强调,肠道和血液中共生微生物群的失调参与了CKD的进展。特别是,血液中[此处原文缺失相关物质,无法准确翻译]的富集成为CKD及其伴随的VC的一个潜在危险因素。